• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过噬菌体与胞外多糖解聚酶Dpo7联合使用实现生物膜的协同去除。

Synergistic removal of biofilms by using a combination of phage with the exopolysaccharide depolymerase Dpo7.

作者信息

Duarte Ana Catarina, Fernández Lucía, Jurado Andrea, Campelo Ana Belén, Shen Yang, Rodríguez Ana, García Pilar

机构信息

Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Villaviciosa, Spain.

DairySafe Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.

出版信息

Front Microbiol. 2024 Aug 7;15:1438022. doi: 10.3389/fmicb.2024.1438022. eCollection 2024.

DOI:10.3389/fmicb.2024.1438022
PMID:39171257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11335607/
Abstract

INTRODUCTION

Bacteriophages have been shown to penetrate biofilms and replicate if they find suitable host cells. Therefore, these viruses appear to be a good option to tackle the biofilm problem and complement or even substitute more conventional antimicrobials. However, in order to successfully remove biofilms, in particular mature biofilms, phages may need to be administered along with other compounds. Phage-derived proteins, such as endolysins or depolymerases, offer a safer alternative to other compounds in the era of antibiotic resistance.

METHODS

This study examined the interactions between phage with a polysaccharide depolymerase (Dpo7) from another phage () against biofilms formed by different strains, as determined by crystal violet staining, viable cell counts and microscopy analysis.

RESULTS AND DISCUSSION

Our results demonstrated that there was synergy between the two antimicrobials, with a more significant decreased in biomass and viable cell number with the combination treatment compared to the phage and enzyme alone. This observation was confirmed by microscopy analysis, which also showed that polysaccharide depolymerase treatment reduced, but did not eliminate extracellular matrix polysaccharides. Activity assays on mutant strains did not identify teichoic acids or PNAG/PIA as the exclusive target of Dpo7, suggesting that may be both are degraded by this enzyme. Phage adsorption to cells was not significantly altered by incubation with Dpo7, indicating that the mechanism of the observed synergistic interaction is likely through loosening of the biofilm structure. This would allow easier access of the phage particles to their host cells and facilitate infection progression within the bacterial population.

摘要

引言

噬菌体已被证明能够穿透生物膜,并且如果找到合适的宿主细胞就会进行复制。因此,这些病毒似乎是解决生物膜问题以及补充甚至替代更传统抗菌剂的一个很好的选择。然而,为了成功去除生物膜,特别是成熟的生物膜,噬菌体可能需要与其他化合物一起使用。在抗生素耐药性的时代,噬菌体衍生的蛋白质,如内溶素或解聚酶,提供了一种比其他化合物更安全的选择。

方法

本研究通过结晶紫染色、活菌计数和显微镜分析,检测了一种噬菌体与另一种噬菌体()的多糖解聚酶(Dpo7)之间针对不同菌株形成的生物膜的相互作用。

结果与讨论

我们的结果表明这两种抗菌剂之间存在协同作用,与单独使用噬菌体和酶相比,联合处理使生物量和活菌数量有更显著的减少。显微镜分析证实了这一观察结果,该分析还表明多糖解聚酶处理减少但并未消除细胞外基质多糖。对突变菌株的活性测定未确定磷壁酸或PNAG/PIA是Dpo7的唯一靶标,这表明两者可能都被该酶降解。与Dpo7孵育后,噬菌体对细胞的吸附没有显著改变,这表明观察到的协同相互作用机制可能是通过生物膜结构的松散。这将使噬菌体颗粒更容易接近其宿主细胞,并促进细菌群体内的感染进程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/55f716111934/fmicb-15-1438022-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/ebbf6a49f708/fmicb-15-1438022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/8640ae42d0d2/fmicb-15-1438022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/6400f18103e4/fmicb-15-1438022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/93137d730902/fmicb-15-1438022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/95b7ee9c60ce/fmicb-15-1438022-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/23899b25e65f/fmicb-15-1438022-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/55f716111934/fmicb-15-1438022-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/ebbf6a49f708/fmicb-15-1438022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/8640ae42d0d2/fmicb-15-1438022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/6400f18103e4/fmicb-15-1438022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/93137d730902/fmicb-15-1438022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/95b7ee9c60ce/fmicb-15-1438022-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/23899b25e65f/fmicb-15-1438022-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc53/11335607/55f716111934/fmicb-15-1438022-g007.jpg

相似文献

1
Synergistic removal of biofilms by using a combination of phage with the exopolysaccharide depolymerase Dpo7.通过噬菌体与胞外多糖解聚酶Dpo7联合使用实现生物膜的协同去除。
Front Microbiol. 2024 Aug 7;15:1438022. doi: 10.3389/fmicb.2024.1438022. eCollection 2024.
2
Role of the Pre-neck Appendage Protein (Dpo7) from Phage vB_SepiS-phiIPLA7 as an Anti-biofilm Agent in Staphylococcal Species.噬菌体vB_SepiS-phiIPLA7的颈部前附属蛋白(Dpo7)作为葡萄球菌属抗生物膜剂的作用。
Front Microbiol. 2015 Nov 25;6:1315. doi: 10.3389/fmicb.2015.01315. eCollection 2015.
3
Synergistic Removal of Static and Dynamic Biofilms by Combined Treatment with a Bacteriophage Endolysin and a Polysaccharide Depolymerase.噬菌体溶素与多糖降解酶联合处理协同去除静态和动态生物膜。
Viruses. 2018 Aug 18;10(8):438. doi: 10.3390/v10080438.
4
Synergistic action of phage phiIPLA-RODI and lytic protein CHAPSH3b: a combination strategy to target Staphylococcus aureus biofilms.噬菌体phiIPLA - RODI与裂解蛋白CHAPSH3b的协同作用:一种靶向金黄色葡萄球菌生物膜的联合策略。
NPJ Biofilms Microbiomes. 2021 Apr 22;7(1):39. doi: 10.1038/s41522-021-00208-5.
5
Real-Time Assessment of Biofilm Disruption by Phage-Derived Proteins.噬菌体衍生蛋白对生物膜破坏的实时评估
Front Microbiol. 2017 Aug 24;8:1632. doi: 10.3389/fmicb.2017.01632. eCollection 2017.
6
The Behavior of Staphylococcus aureus Dual-Species Biofilms Treated with Bacteriophage phiIPLA-RODI Depends on the Accompanying Microorganism.用噬菌体phiIPLA-RODI处理的金黄色葡萄球菌双物种生物膜的行为取决于伴随的微生物。
Appl Environ Microbiol. 2017 Jan 17;83(3). doi: 10.1128/AEM.02821-16. Print 2017 Feb 1.
7
Potential of phage depolymerase for the treatment of bacterial biofilms.噬菌体脱聚酶在治疗细菌生物膜中的潜力。
Virulence. 2023 Dec;14(1):2273567. doi: 10.1080/21505594.2023.2273567. Epub 2023 Oct 31.
8
Two Phages, phiIPLA-RODI and phiIPLA-C1C, Lyse Mono- and Dual-Species Staphylococcal Biofilms.两种噬菌体phiIPLA-RODI和phiIPLA-C1C可裂解单菌种和双菌种葡萄球菌生物膜。
Appl Environ Microbiol. 2015 May 15;81(10):3336-48. doi: 10.1128/AEM.03560-14. Epub 2015 Mar 6.
9
Characterization of a New Staphylococcus aureus Kayvirus Harboring a Lysin Active against Biofilms.一株携带针对生物膜裂解酶的新型金黄色葡萄球菌噬菌体的鉴定。
Viruses. 2018 Apr 7;10(4):182. doi: 10.3390/v10040182.
10
σ Inhibits Poly--Acetylglucosamine Exopolysaccharide Synthesis and Biofilm Formation in .σ 抑制 聚-N-乙酰葡糖胺多糖的生物合成和生物膜形成。
J Bacteriol. 2019 May 8;201(11). doi: 10.1128/JB.00098-19. Print 2019 Jun 1.

引用本文的文献

1
Efficacy of phage therapy in controlling staphylococcal biofilms: a systematic review.噬菌体疗法在控制葡萄球菌生物膜方面的疗效:一项系统综述。
Eur J Med Res. 2025 Jul 9;30(1):605. doi: 10.1186/s40001-025-02781-3.
2
Multipronged impact of environmental temperature on Staphylococcus aureus infection by phage Kayvirus rodi: Implications for biofilm control.环境温度对噬菌体Kayvirus rodi感染金黄色葡萄球菌的多方面影响:对生物膜控制的启示
Biofilm. 2024 Dec 28;9:100248. doi: 10.1016/j.bioflm.2024.100248. eCollection 2025 Jun.
3
Response of to combination of virulent bacteriophage vB_SauM-515A1 and linezolid.

本文引用的文献

1
Characterization of Ssc, an -acetylgalactosamine-containing surface polysaccharide.Ssc 的特征分析,一种含有 N-乙酰半乳糖胺的表面多糖。
J Bacteriol. 2024 May 23;206(5):e0004824. doi: 10.1128/jb.00048-24. Epub 2024 May 7.
2
Prevalence of virulence- and antibiotic resistance-associated genotypes and phenotypes in strains from the food sector compared to clinical and cow mastitis isolates.食品源 与临床和奶牛乳腺炎分离株相比,菌株的毒力和抗生素耐药相关基因型和表型的流行率。
Front Cell Infect Microbiol. 2024 Jan 29;14:1327131. doi: 10.3389/fcimb.2024.1327131. eCollection 2024.
3
Potential of phage depolymerase for the treatment of bacterial biofilms.
[未提及的对象]对烈性噬菌体vB_SauM - 515A1与利奈唑胺联合用药的反应。
Front Microbiol. 2024 Dec 20;15:1519312. doi: 10.3389/fmicb.2024.1519312. eCollection 2024.
4
Characterization of a phage 4FS1 and its depolymerase.噬菌体4FS1及其解聚酶的特性分析
Front Vet Sci. 2024 Nov 25;11:1496684. doi: 10.3389/fvets.2024.1496684. eCollection 2024.
噬菌体脱聚酶在治疗细菌生物膜中的潜力。
Virulence. 2023 Dec;14(1):2273567. doi: 10.1080/21505594.2023.2273567. Epub 2023 Oct 31.
4
Class-Driven Synergy and Antagonism between a Pseudomonas Phage and Antibiotics.基于类别的噬菌体与抗生素协同与拮抗作用
Infect Immun. 2023 Aug 16;91(8):e0006523. doi: 10.1128/iai.00065-23. Epub 2023 Jul 5.
5
Biology and Regulation of Staphylococcal Biofilm.葡萄球菌生物膜的生物学与调控
Int J Mol Sci. 2023 Mar 9;24(6):5218. doi: 10.3390/ijms24065218.
6
Comparison of the therapeutic potential of bacteriophage KpV74 and phage-derived depolymerase (β-glucosidase) against Klebsiella pneumoniae capsular type K2.噬菌体 KpV74 与噬菌体衍生的解聚酶(β-葡萄糖苷酶)治疗 K 型肺炎克雷伯菌的潜力比较
Virus Res. 2022 Dec;322:198951. doi: 10.1016/j.virusres.2022.198951. Epub 2022 Sep 30.
7
Characterization of Novel Bacteriophage vB_KpnP_ZX1 and Its Depolymerases with Therapeutic Potential for K57 Infection.新型噬菌体vB_KpnP_ZX1及其解聚酶对K57感染的治疗潜力表征
Pharmaceutics. 2022 Sep 10;14(9):1916. doi: 10.3390/pharmaceutics14091916.
8
Benefits of Combined Phage-Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review.联合噬菌体-抗生素疗法控制耐药菌的益处:文献综述
Antibiotics (Basel). 2022 Jun 22;11(7):839. doi: 10.3390/antibiotics11070839.
9
The Specific Capsule Depolymerase of Phage PMK34 Sensitizes to Serum Killing.噬菌体PMK34的特异性荚膜解聚酶对血清杀伤敏感。
Antibiotics (Basel). 2022 May 17;11(5):677. doi: 10.3390/antibiotics11050677.
10
Bacteriophage-Ciprofloxacin Combination Effectiveness Depends on - Dual-Species Communities' Growth Model.噬菌体-环丙沙星联合有效性取决于-双物种群落生长模型。
Microb Drug Resist. 2022 Jun;28(6):613-622. doi: 10.1089/mdr.2021.0324. Epub 2022 Apr 11.